Zusammenfassung
Die Häufigkeit des Diabetes mellitus wird in den westlichen Industriestaaten auf 6–8% geschätzt. Alters- und populationsabhängig kann die Prävalenz wesentlich höhere Werte erreichen und beträgt bei Pima-Indianern (Arizona/USA) im Alter über 20 Jahren 34%.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Boccuzzi SJ, Wogen J, Fox J et al (2001) Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care 24:1411–1415
Caro JJ, Ward AJ, O’Brien JA (2002) Lifetime costs of complications resulting from type 2 diabetes in the US. Diabetes Care 25:476–481
Chaturvedi N, Stevens LK, Fuller JH et al, WHO Multinational Study Group (2001) Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of vascular disease in diabetes. Diabetologia 44(Suppl. 2): S65–S71
Colditz GA, Willett WC, Stampfer MJ et al (1990): Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132:501–513
Derfler K, Waldhäusl W, Zyman J et al (1986) Diabetes care in rural area: Clinical and metabolic evaluation. Diabetes Care 9:509–517
Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403
Gaede P, Vedel P, Larsen N et al (2003) Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. NEJM 348:383–393
Gale EAM (2002) The rise of childhood type 1 diabetes in the 20th century. Diabetes 51:3353–3361
Gu K, Gowie CC, Harris MI (1998) Mortality in adults with and without diabetes in a national cohort of the US population, 1971–1993. Diabetes Care 21:1138–1145
Harris MI, Flegal KM, Cowie CC et al (1998): Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 21:518–524
Jönsson B (2002) Revealing the cost of Type II diabetes in Europe. Diabetologia 45: S5–S12
Liebl A, Spannheimer A, Reitberger U, Görtz A (2002) Kosten für Spätkomplikationen bei Diabetes mellitus Typ 2 in Deutschland. Ergebnisse der CODE-2-Studie. Med Klin 97: 713–719
Liebl A, Spannheimer A, Reitberger U, Görtz A (2003) Arzneimitteltherapie und Medikamenten kosten von Patienten mit Typ-2-Diabetes in Deutschland. Diabetes und Stoffwechsel 12:145–151
Loewel H, Koenig W, Engel S (2000) The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43:218–226
Malmberg K, Norhammar A, Wedel H, Ryden L (1999) Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the diabetes and insulin-glucose infusion in acute myocardial infarction (DIGAMI) study. Circulation 99:2626–2632
McKinally J, Marceau L (2000): US public health and the 21st century: diabetes mellitus. Lancet 356:757–761
Morrish NJ, Wang SL, Stevens LK, Fuller JH et al, WHO Multinational Study Group (2001) Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia 44(Suppl.2):S14–S21
Mühlhauser I, Overmann H, Bender R et al (1998) Social status and the quality of care for adult people with Type 1 (insulin-dependent) diabetes mellitus — a population-based study. Diabetologia 41:1139–1150
Peters AL, Legorreta AP, Ossorio RC, Davidson MB (1996) Quality of outpatient care provided to diabetic patients. Diabetes Care 19:601–606
Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4.400 patients observed between 1947 and 1973. Diabetes Care 21:168–188; 252–263
Rathmann W, Haastert B, Roseman JM et al (1998) Prescription drug use and costs among diabetic patients in primary health care practices in Germany. Diabetes Care 21: 389–397
Ratzmann KP, Gorr K, Schneider H (1994) Prävalenz diabetes-bedingter Erblindungen. Eine Populationsstudie an 70.203 Diabetikern. Diabetes und Stoffwechsel 3:261–264
Scherbaum WA (2002) Insulin therapy in Europe. Diabetes Metab Res Rev 18:550–556
Sinha R, Fisch G, Teaque B et al (2002) Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 346:802–810
Soltesz G (2003) Diabetes in the young:a paediatric and epidemiological perspective. Diabetologia 46:447–454
Taubert G, Winkelmann BR, Schleiffer T et al. (2003) Prevalence, predictors, and consequences of unrecognized diabetes mellitus in 3266 patients scheduled for coronary angiography. Am Heart J, 145:285–291
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Tuomilehto J, Lindström J, Eriksson JG et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
UK Prospective Study Group (1998): Intensive blood glucose control with sulfonylurea or with insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837–853
Waldhäusl W, Howorka K, Derfler K et al (1985) Failure and efficacy of insulin therapy in insulin dependent (type I) diabetic patients. Acta Diabetol Lat 22:279–294
Waldhäusl W (1990) Rational treatment of NIDDM. Does it exist? Diabetes, Nutrition, Metabolism Reviews 4:259–265
Williams KJ (2002) EditoriahThe mystery — and importance — of diabetic atherosclerotic vascular disease. J Clin Endocrinol Metab 87:33–34
Zimmet PZ (1999) Diabetes epidemiology as a tool to trigger diabetes research and care. Diabetologia 42:499–518
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Waldhäusl, W., Scherbaum, W.A. (2004). Epidemiologie des Diabetes mellitus und Stand der Diabetesbetreuung. In: Waldhäusl, W.K., Gries, F.A., Scherbaum, W.A. (eds) Diabetes in der Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18571-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-18571-7_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62166-6
Online ISBN: 978-3-642-18571-7
eBook Packages: Springer Book Archive